Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103972287 | 10397228 | 7 | F | 201408 | 20160815 | 20140820 | 20160819 | EXP | US-PFIZER INC-2014229322 | PFIZER | 87.00 | YR | F | Y | 63.00000 | KG | 20160819 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103972287 | 10397228 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 75 MG, 2X/DAY | 21446 | 75 | MG | CAPSULE, HARD | BID | ||||||
| 103972287 | 10397228 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 2X/DAY, (1 CAPSULE TWICE A DAY 90 DAYS) | 21446 | 150 | MG | CAPSULE, HARD | BID | ||||||
| 103972287 | 10397228 | 3 | C | ALENDRONATE | ALENDRONATE SODIUM | 1 | 70 MG, UNK | 0 | 70 | MG | |||||||||
| 103972287 | 10397228 | 4 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | UNK | 0 | |||||||||||
| 103972287 | 10397228 | 5 | C | BABY ASPIRIN | ASPIRIN | 1 | 81 MG, UNK | 0 | 81 | MG | |||||||||
| 103972287 | 10397228 | 6 | C | ATENOLOL. | ATENOLOL | 1 | 25 MG, UNK | 0 | 25 | MG | |||||||||
| 103972287 | 10397228 | 7 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | UNK | 0 | BID | ||||||||||
| 103972287 | 10397228 | 8 | C | BUSPIRONE | BUSPIRONE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 103972287 | 10397228 | 9 | C | CALCIUM+D | CALCIUMVITAMIN D | 1 | UNK | 0 | |||||||||||
| 103972287 | 10397228 | 10 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | UNK | 0 | |||||||||||
| 103972287 | 10397228 | 11 | C | FOLIC ACID. | FOLIC ACID | 1 | 1 MG, UNK | 0 | 1 | MG | |||||||||
| 103972287 | 10397228 | 12 | C | FUROSEMIDE. | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 103972287 | 10397228 | 13 | C | ICAPS | MINERALSVITAMINS | 1 | UNK | 0 | |||||||||||
| 103972287 | 10397228 | 14 | C | ISOSORBIDE. | ISOSORBIDE | 1 | 30 MG, UNK | 0 | 30 | MG | |||||||||
| 103972287 | 10397228 | 15 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | UNK | 0 | |||||||||||
| 103972287 | 10397228 | 16 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 30 MG, UNK | 0 | 30 | MG | |||||||||
| 103972287 | 10397228 | 17 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 5 MG, UNK | 0 | 5 | MG | |||||||||
| 103972287 | 10397228 | 18 | C | TRAMADOL. | TRAMADOL | 1 | UNK | 0 | |||||||||||
| 103972287 | 10397228 | 19 | C | NITROSTAT | NITROGLYCERIN | 1 | UNK | 0 | |||||||||||
| 103972287 | 10397228 | 20 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | UNK | 0 | |||||||||||
| 103972287 | 10397228 | 21 | C | PREDNISONE. | PREDNISONE | 1 | 5 MG, UNK | 0 | 5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103972287 | 10397228 | 1 | Neuropathy peripheral |
| 103972287 | 10397228 | 2 | Neuropathy peripheral |
| 103972287 | 10397228 | 13 | Eye disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103972287 | 10397228 | OT |
| 103972287 | 10397228 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103972287 | 10397228 | Pain in extremity | |
| 103972287 | 10397228 | Parkinson's disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103972287 | 10397228 | 1 | 20140420 | 0 |